Specifically, in malignant tumors, especially in myeloma, anti-MHC I antibody selectively induced tumor cell apoptosis, by activating Lyn and PLCγ2 to upregulate proapoptotic Bad and Bax expression [18]. The gene discussed is BAD; the disease is plasma cell myeloma.